Intuitive Surgical EVP Sells $51,938 in Stock

Myriam Curet, an executive vice president at the medical technology company, reduces her stake by over 11%.

Published on Feb. 11, 2026

Got story updates? Submit your updates here. ›

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 105 shares of the company's stock in a transaction on February 10, 2026. The shares were sold at an average price of $494.65, resulting in a total transaction value of $51,938.25. Following the sale, Curet directly owned 830 shares of the company's stock, valued at $410,559.50.

Why it matters

Insider transactions, such as stock sales by company executives, can provide insights into management's views on the company's prospects and valuation. Curet's sale represents a significant reduction in her personal stake in Intuitive Surgical, which may signal her belief that the stock is overvalued or that she has other investment priorities.

The details

Curet's sale of 105 shares represents an 11.23% decrease in her direct ownership of Intuitive Surgical stock. The company is a leading provider of robotic-assisted surgical systems, with its da Vinci platform being widely used in minimally invasive procedures. The stock has seen significant volatility in recent months, with the share price ranging from $425 to $609 over the past year.

  • The stock sale occurred on February 10, 2026.

The players

Myriam Curet

An executive vice president at Intuitive Surgical, Inc., a medical technology company focused on robotic-assisted surgical systems.

Intuitive Surgical, Inc.

A medical technology company that designs, manufactures, and services robotic-assisted surgical systems, including the popular da Vinci platform.

Got photos? Submit your photos here. ›

The takeaway

Curet's stock sale, while not necessarily indicative of broader concerns about Intuitive Surgical's performance, does suggest that at least one senior executive believes the company's shares may be overvalued at current levels. Investors will likely continue to monitor insider transactions and other market signals to gauge the company's long-term prospects.